The European Medicines Agency will review GSK's request to approve its asthma drug Nucala as an additional treatment for ...

Nucala (mepolizumab) is a prescription injection used to treat a type of asthma and other inflammatory conditions. Nucala isn’t known to interact with other drugs, alcohol, or supplements.

Nucala (mepolizumab) and Dupixent (dupilumab) are brand-name subcutaneous injections. They’re both prescribed for asthma and chronic rhinosinusitis with nasal polyps. Each drug may also be ...

GSK on Monday said that the European Medicines Agency has agreed to review a request to approve the British drugmaker's ...

Current health news highlights a 10% rise in child TB infections in Europe, a new drug review by European regulators, the ...

The European Medicines Agency (EMA) has agreed to review GSK’s application of expanding Nucala’s (mepolizumab) use as add-on maintenance for individuals with chronic obstructive pulmonary ...

The price you pay for Nucala may depend on factors such as your health or medical insurance and the pharmacy used. Financial assistance may be available to help you with the cost of Nucala.

GSK (GSK) plc announced that the European Medicines Agency has accepted for review its application to expand the use of Nucala, a monoclonal ...

Recent health news highlights a 10% rise in child TB infections in Europe, detected mammal bird flu cases, and economic ...

GSK ha anunciado hoy que la Agencia Europea de Medicamentos (EMA) ha aceptado revisar su solicitud de ampliar el uso de ...

GSK plc GSK announced that the European Medicines Agency (“EMA”) has accepted for review a regulatory filing, seeking approval for a new indication of its respiratory drug, Nucala (mepolizumab).

GSK said on Monday that the European Medicines Agency has accepted its application to expand the use of ‘Nucala’, or ...